SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
£139.75
Tirzepatide is a synthetic 39-amino-acid polypeptide chain engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Featuring a C20 fatty-diacid moiety conjugated via a flexible linker, it exhibits high-affinity binding across both incretin pathways, making it an essential reference standard for metabolic signaling and bioenergetic research.
Molecular Weight: 4,813.52 g/mol
CAS Number: 2023788-19-2
Physical Form: Lyophilized research peptide powder
Storage: Store at -20°C desiccated
Unlike single-target incretin analogs, this dual-agonist architecture simultaneously activates GIP and GLP-1 receptors to modulate insulinotropic activity and energy expenditure pathways. Academic and institutional laboratories utilize this compound to analyze:
Cellular Signaling Kinetics: Probing cyclic-AMP (cAMP) production and receptor-complex internalization in vitro.
Comparative Incretin Assays: Serving as a benchmark alongside emerging multi-agonist sequences, including investigations relative to a retatrutide peptide control.
Metabolic Pathways: Evaluating downstream lipid metabolism, glucose homeostasis, and adipocyte receptor responses.
When planning complex analytical protocols, researchers frequently analyze economic variables, including the baseline tirzepatide cost across certified chemical suppliers. Laboratories evaluating options for tirzepatide online acquisition require rigorous third-party verification, such as mass spectrometry and HPLC purity data.
For institutional teams scanning local availability or searching for tirzepatide near me to support immediate in-vitro applications, ensuring batch-to-batch structural integrity remains critical to prevent peptide degradation or sequence truncation.
Receptor Chemicals delivers high-purity research compounds synthesized to exacting scientific specifications. Each batch undergoes rigorous high-performance liquid chromatography validation to ensure optimal stability and experimental reproducibility for advanced bioenergetic studies.